Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Core Viewpoint - The market anticipates Alector (ALEC) will report a year-over-year increase in earnings despite lower revenues, with actual results being crucial for stock price movement [1][2]. Company Summary - Alector is expected to report a quarterly loss of $0.42 per share, reflecting a year-over-year change of +2.3% [3]. - Revenues are projected to be $2.63 million, down 82.9% from the same quarter last year [3]. - The consensus EPS estimate has been revised 3.13% lower in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Alector's Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.77% [12]. - Alector currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [12]. Historical Performance - In the last reported quarter, Alector was expected to post a loss of $0.45 per share but actually reported a loss of -$0.30, achieving a surprise of +33.33% [13]. - Over the past four quarters, Alector has beaten consensus EPS estimates four times [14]. Industry Context - Another company in the same industry, AC Immune (ACIU), is expected to report a loss of $0.22 per share, indicating a year-over-year change of -466.7% [18]. - AC Immune's revenues are expected to be $1.52 million, down 94.8% from the previous year [18]. - The consensus EPS estimate for AC Immune has been revised 4.3% higher in the last 30 days, but it also has a negative Earnings ESP of -4.55% [19][20].